Inventor · disambiguated record
Sajan Joseph
Also filed as: JOSEPH SAJAN
26 granted patents·5 pending applications·259 citations·filing 1999–2024
95Inventor score
Top patents by PatentIndex Score
31 records- 0195US7449477B27-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B)LILLY CO ELI·Filed 2004·Granted Nov 11, 2008·68 cites·9 claims
- 0293US6635657B1Aromatic amidesLILLY CO ELI·Filed 1999·Granted Oct 21, 2003·56 cites·24 claims
- 0389US7160878B2Substituted heterocyclic amidesLILLY CO ELI·Filed 2001·Granted Jan 9, 2007·24 cites·13 claims
- 0485US6610704B1Antithrombotic amidesLILLY CO ELI·Filed 1999·Granted Aug 26, 2003·24 cites·12 claims
- 0584US7700628B2Aromatic ether derivatives useful as thrombin inhibitorsLILLY CO ELI·Filed 2005·Granted Apr 20, 2010·5 cites·21 claims
- 0684US7163938B2Substituted carboxamidesLILLY CO ELI·Filed 2001·Granted Jan 16, 2007·15 cites·20 claims
- 0783US9617243B2Aminopyridyloxypyrazole compoundsLILLY CO ELI·Filed 2015·Granted Apr 11, 2017·6 cites·12 claims
- 0883US9469652B2ERK inhibitorsLILLY CO ELI·Filed 2015·Granted Oct 18, 2016·2 cites·42 claims
- 0982US6867198B2Agents and methods for the treatment of proliferative diseasesLILLY CO ELI·Filed 2000·Granted Mar 15, 2005·15 cites·8 claims
- 1080US7998977B2Inhibitors of AKT (protein kinase B)LILLY CO ELI·Filed 2007·Granted Aug 16, 2011·7 cites·16 claims
- 1178US6759414B2Aromatic amidesLILLY CO ELI·Filed 2003·Granted Jul 6, 2004·7 cites·24 claims
- 1276US9526733B1ERK inhibitorsLILLY CO ELI·Filed 2016·Granted Dec 27, 2016·1 cites·8 claims
- 1375US8093383B2P70 S6 kinase inhibitorsJOSEPH SAJAN·Filed 2009·Granted Jan 10, 2012·2 cites·3 claims
- 1474US9067920B2Compounds useful for inhibiting Chk1JOSEPH SAJAN·Filed 2011·Granted Jun 30, 2015·3 cites·10 claims
- 1574US6689780B1Heteroroaromatic amides as inhibitor of factor XaLILLY CO ELI·Filed 1999·Granted Feb 10, 2004·18 cites·13 claims
- 1673US8148387B2AKT and P70 S6 kinase inhibitorsSHEPHERD TIMOTHY ALAN·Filed 2009·Granted Apr 3, 2012·3 cites·17 claims
- 1767USRE48635EERK inhibitorsLILLY CO ELI·Filed 2019·Granted Jul 13, 2021·0 cites·42 claims
- 1866US2024360137A1Cyclin-dependent kinase (cdk2) inhibitorsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1960US6743785B2Agents and methods for the treatment of proliferative diseasesLILLY CO ELI·Filed 2000·Granted Jun 1, 2004·2 cites·10 claims
- 2056US7414063B2Inhibitors of Akt (protein kinase B)LILLY CO ELI·Filed 2004·Granted Aug 19, 2008·1 cites·12 claims
- 2156US6780878B2Antithrombotic amidesLILLY CO ELI·Filed 2003·Granted Aug 24, 2004·0 cites·10 claims
- 2256US6710057B2Antithrombotic amidesLILLY CO ELI·Filed 2003·Granted Mar 23, 2004·0 cites·11 claims
- 2356US2025092016A1Compounds and compositions for the treatment of coronaviral related diseasesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2453US7129245B2Aromatic amidesLILLY CO ELI·Filed 2003·Granted Oct 31, 2006·0 cites·24 claims
- 2553US6716839B2Antithrombotic amidesLILLY CO ELI·Filed 2003·Granted Apr 6, 2004·0 cites·11 claims
- 2653US6716855B2Antithrombotic amidesLILLY CO ELI·Filed 2003·Granted Apr 6, 2004·0 cites·11 claims
- 2748US2022153750A1Salts of 5,6-dihydro-4h-thieno[2,3-c]pyrrol-4-one compound as erk inhibitorsLILLY CO ELI·Filed 2020·Application pending·0 cites
- 2848US2022168250A1TRIPLE COMBINATION OF AN ERK1/2 INHIBITOR WITH A BRAF INHIBITOR AND AN EGFR INHIBITOR FOR USE IN THE TREATMENT OF BRAFv6ooE COLORECTAL CANCERLILLY CO ELI·Filed 2020·Application pending·0 cites
- 2944US2012071490A1P70 s6 kinase inhibitorsDALLY ROBERT DEAN·Filed 2011·Application pending·0 cites
- 3042US7449457B2Substituted heterocyclic carboxamides with antithrombotic activityLILLY CO ELI·Filed 2002·Granted Nov 11, 2008·0 cites·11 claims
- 3137US9879029B2ERK inhibitorsLILLY CO ELI·Filed 2015·Granted Jan 30, 2018·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Sajan Joseph files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →